Management of diarrhea induced by EGFR-TKIs in advanced lung adenocarcinoma

The identification of Epidermal Growth Factor Receptor (EGFR) mutations in lung adenocarcinoma has facilitated the development of personalized medicine based on oncogenic drivers. EGFR-Tyrosine Kinase Inhibitors (TKIs) are part of the targeted therapy; they impede the phosphorylation of the intracel...

Descripción completa

Detalles Bibliográficos
Autores principales: Cárdenas-Fernández, Daniela, Soberanis Pina, Pamela, Turcott, Jenny G., Chávez-Tapia, Norberto, Conde-Flores, Emilio, Cardona, Andrés F., Arrieta, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467292/
https://www.ncbi.nlm.nih.gov/pubmed/37655206
http://dx.doi.org/10.1177/17588359231192396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467292/
https://www.ncbi.nlm.nih.gov/pubmed/37655206
http://dx.doi.org/10.1177/17588359231192396

Ejemplares similares